Condition
Blood Purification
Total Trials
6
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
17%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 3 (1)
Trial Status
Completed2
Not Yet Recruiting2
Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07419802Recruiting
OxiCLEAR (Oxiris Cytokines and Endotoxin Adsorption Rate) Study
NCT05595239Not ApplicableNot Yet Recruiting
Blood Purification in Septic Children
NCT06807151Completed
Leveraging Plasma Concentration Levels to Optimize Extracorporeal Treatment in Acute Diquat Poisoning
NCT06504316Not ApplicableNot Yet Recruiting
OXiris for Abdominal SEptic Shock (OASES Study)
NCT04643639Phase 3Completed
Assessing the Effects of CytoSorb Hemoperfusion on the Development on Immunoparalysis
NCT05510713Not ApplicableUnknownPrimary
Blood Purification Therapy With Dual-cannula in Jugular-femoral Venous
Showing all 6 trials